Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced that it will present posters highlighting new ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Teresa Carr Vitamin prices are confounding—and they vary wildly. You ...